Skip to content

Study on the effects of different drugs on endometrial repair after induced abortion

Study on the effects of different drugs on endometrial repair after induced abortion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013242
Enrollment
Unknown
Registered
2017-11-04
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abortion

Interventions

contraception :oral contraception
femoston:oral femoston

Sponsors

Liuzhou Maternal and Child Healthcare Hospital, Guangxi Province, China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 42 years; 2. the uterus pregnancy to be confirmed by Ultrasonic B examination, and voluntary to terminate the pregnancy, and the gestational week is 5 ~ 14 weeks; 3. regular previous menstrual, the cycle 28±7 days; 4. no sex hormone has been used recently, normal liver and kidney function, no breast disease, no oral contraceptive pill, no 17 beta-estradiol taboo; 5. no operation history of the uterus in nearly three months; 6. no contraindication of surgical, anaesthesia, and general anesthesia. ;Inclusion criteria: 1. aged 18 to 42 years; 2. the uterus pregnancy to be confirmed by Ultrasonic B examination, and voluntary to terminate the pregnancy, and the gestational week is 5 ~ 14 weeks; 3. regular previous menstrual, the cycle 28±7 days; 4. no sex hormone has been used recently, normal liver and kidney function, no breast disease, no oral contraceptive pill, no 17 beta-estradiol taboo; 5. no operation history of the uterus in nearly three months; 6. no contraindication of surgical, anaesthesia, and general anesthesia. ;Inclusion criteria: 1. aged 18 to 42 years; 2. the uterus pregnancy to be confirmed by Ultrasonic B examination, and voluntary to terminate the pregnancy, and the gestational week is 5 ~ 14 weeks; 3. regular previous menstrual, the cycle 28±7 days; 4. no sex hormone has been used recently, normal liver and kidney function, no breast disease, no oral contraceptive pill, no 17 beta-estradiol taboo; 5. no operation history of the uterus in nearly three months; 6. no contraindication of surgical, anaesthesia, and general anesthesia. ;Inclusion criteria: 1. aged 18 to 42 years; 2. the uterus pregnancy to be confirmed by Ultrasonic B examination, and voluntary to terminate the pregnancy, and the gestational week is 5 ~ 14 weeks; 3. regular previous menstrual, the cycle 28±7 days; 4. no sex hormone has been used recently, normal liver and kidney function, no breast disease, no oral contraceptive pill, no 17 beta-estradiol taboo; 5. no operation history of the uterus in nearly three months; 6. no contraindication of surgical, anaesthesia, and general anesthesia. ;Inclusion criteria: 1. aged 18 to 42 years; 2. the uterus pregnancy to be confirmed by Ultrasonic B examination, and voluntary to terminate the pregnancy, and the gestational week is 5 ~ 14 weeks; 3. regular previous menstrual, the cycle 28±7 days; 4. no sex hormone has been used recently, normal liver and kidney function, no breast disease, no oral contraceptive pill, no 17 beta-estradiol taboo; 5. no operation history of the uterus in nearly three months; 6. no contraindication of surgical, anaesthesia, and general anesthesia.

Exclusion criteria

Exclusion criteria: 1. acute stages of various diseases; 2. genital inflammation, such as vaginitis, acute cervicitis, acute and chronic alonitis, sexually transmitted diseases, etc., untreated; 3. The whole body is not able to tolerate the operation; 4. the preoperative temperature was greater than 37.5 and the operation was postponed; 5. history of allergic constitution, allergic asthma history, narcotic drugs and a variety of drug allergy history.;Exclusion criteria: 1. acute stages of various diseases; 2. genital inflammation, such as vaginitis, acute cervicitis, acute and chronic alonitis, sexually transmitted diseases, etc., untreated; 3. The whole body is not able to tolerate the operation; 4. the preoperative temperature was greater than 37.5 and the operation was postponed; 5. history of allergic constitution, allergic asthma history, narcotic drugs and a variety of drug allergy history.;Exclusion criteria: 1. acute stages of various diseases; 2. genital inflammation, such as vaginitis, acute cervicitis, acute and chronic alonitis, sexually transmitted diseases, etc., untreated; 3. The whole body is not able to tolerate the operation; 4. the preoperative temperature was greater than 37.5 and the operation was postponed; 5. history of allergic constitution, allergic asthma history, narcotic drugs and a variety of drug allergy history.;Exclusion criteria: 1. acute stages of various diseases; 2. genital inflammation, such as vaginitis, acute cervicitis, acute and chronic alonitis, sexually transmitted diseases, etc., untreated; 3. The whole body is not able to tolerate the operation; 4. the preoperative temperature was greater than 37.5 and the operation was postponed; 5. history of allergic constitution, allergic asthma history, narcotic drugs and a variety of drug allergy history.;Exclusion criteria: 1. acute stages of various diseases; 2. genital inflammation, such as vaginitis, acute cervicitis, acute and chronic alonitis, sexually transmitted diseases, etc., untreated; 3. The whole body is not able to tolerate the operation; 4. the preoperative temperature was greater than 37.5 and the operation was postponed; 5. history of allergic constitution, allergic asthma history, narcotic drugs and a variety of drug allergy history.

Design outcomes

Primary

MeasureTime frame
Endometrial thickness;intrauterine adhesions;

Secondary

MeasureTime frame
Vaginal bleeding days;The time of first menstrual recovery;Changes in menstrual flow;

Countries

China

Contacts

Public ContactLin Zhong;Lin Zhong;Lin Zhong;Lin Zhong;Lin Zhong ;;;;

Liuzhou maternal and Child Healthcare Hospital?;Liuzhou maternal and Child Healthcare Hospital?;Liuzhou maternal and Child Healthcare Hospital?;Liuzhou maternal and Child Healthcare Hospital?;Liuzhou maternal and Child Healthcare Hospital?

huangpinxiu@163.com;huangpinxiu@163.com;huangpinxiu@163.com;huangpinxiu@163.com;huangpinxiu@163.com+86 18377285169;+86 18377285169;+86 18377285169;+86 18377285169;+86 18377285169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026